ML Strategies

As part of the Healey–Driscoll administration’s continued efforts to ensure Massachusetts remains a state where people want to live, work, and raise families — and businesses want to start and operate companies — the administration announced the proposed Mass Leads Act earlier today. The proposed law calls for investments of $1 billion each in the life sciences and climate tech industries over a 10-year period, with the latter category of funding providing critically important support to the administration’s goal of making Massachusetts the global leader in climate tech and clean energy development. 

Read about Sprint for Women’s Health, a first-of-its-kind initiative to commit $100 million for research and development in women’s health, announced by the Advanced Research Projects Agency for Health.

This issue of Energy & Sustainability Connections includes features on Mintz’s commitment to the energy transition with 80+ deal closings totaling $4 billion in the past 12 months and public benefit company Cultivo, a roundup of recent M&A activity in the energy space, energy policy news from Washington, litigation updates, and a list of upcoming industry events.

Learn about upcoming energy industry events, including the ACCEL: Advancing Climatetech & Clean Energy Leaders, Year 2 Kickoff Event co-hosted by Greentown Labs and Browning the Green Space.

Read about AI-focused task forces formed in the House of Representatives and by the governor of Massachusetts in the latest edition of AI: The Washington Report, a joint undertaking of Mintz and ML Strategies covering potential federal legislative, executive, and regulatory activities related to AI.

Read about the Department of Commerce’s new cross-sector consortium on AI safety in the latest edition of AI: The Washington Report, a joint undertaking of Mintz and ML Strategies covering potential federal legislative, executive, and regulatory activities related to AI. 

Read about the Preventing Algorithmic Collusion Act, a bill that seeks to ban anticompetitive pricing practices deployed through AI, in the latest edition of AI: The Washington Report, a joint undertaking of Mintz and ML Strategies covering potential federal legislative, executive, and regulatory activities related to AI.

Read about major milestones achieved in response to President Biden’s October 2023 executive order on AI in the latest edition of AI: The Washington Report, a joint undertaking of Mintz and ML Strategies covering potential federal legislative, executive, and regulatory activities related to AI.

Read about the FTC’s use of a remedy known as “algorithmic disgorgement” in settlements with AI companies in the latest edition of AI: The Washington Report, a joint undertaking of Mintz and ML Strategies covering potential federal legislative, executive, and regulatory activities related to AI. 

Read about the FTC’s business guidance blog post discussing its resolve to enforce the privacy commitments of certain AI firms known as “model-as-a-service” companies in the latest edition of AI: The Washington Report, a joint undertaking of Mintz and ML Strategies covering potential federal legislative, executive, and regulatory activities related to AI.

Read about the ongoing debate surrounding the use of copyrighted works as training data for AI models in the latest edition of AI: The Washington Report, a joint undertaking of Mintz and ML Strategies covering potential federal legislative, executive, and regulatory activities related to AI.

Read about Chief Justice Roberts’s end-of-the-year letter on AI and the federal judiciary in the latest edition of AI: The Washington Report, a joint undertaking of Mintz and ML Strategies covering potential federal legislative, executive, and regulatory activities related to AI.

Read about three broad trends that shaped AI regulation in 2023 in the year-end edition of AI: The Washington Report, a joint undertaking of Mintz and ML Strategies covering potential federal legislative, executive, and regulatory activities related to AI.

In 2023, the FDA navigated challenges while achieving significant public health milestones. Member Joanne Hawana and Of Counsel Benjamin Zegarelli highlight key takeaways from the year, addressing multifaceted issues such as CBD regulation, the overhaul of in vitro clinical tests, and the management of manufacturing failures. These pivotal topics underscore the FDA’s proactive approach to evolving healthcare regulations and technological advancements. 

Read about a Senate Judiciary Committee hearing addressing the impact of algorithms on competition and consumer rights in the latest edition of AI: The Washington Report, a joint undertaking of Mintz and ML Strategies covering potential federal legislative, executive, and regulatory activities related to AI.

Read about the SEC’s warnings about “AI-washing” and stiff industry opposition to its proposed rules for conflicts of interest in the use of predictive data analytics technologies by broker-dealers and investment advisers in the latest edition of AI: The Washington Report, a joint undertaking of Mintz and ML Strategies covering potential federal legislative, executive, and regulatory activities related to AI.

Read about workplace implications of president biden’s executive order addressing artificial intelligence in the latest edition of AI: The Washington Report, a joint undertaking of Mintz and ML Strategies covering potential federal legislative, executive, and regulatory activities related to AI.

See a timeline of Biden’s AI Executive Order, which details when some of the EO’s major provisions will come into effect, in the latest edition of AI: The Washington Report, a joint undertaking of Mintz and ML Strategies covering potential federal legislative, executive, and regulatory activities related to AI.

Read about the FTC’s preauthorization of a compulsory process in investigations relating to AI and a new AI bill supported by a bipartisan group of Commerce Committee senators in the latest edition of AI: The Washington Report, a joint undertaking of Mintz and ML Strategies covering potential federal legislative, executive, and regulatory activities related to AI.